Stomach Neoplasms

"Stomach Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the STOMACH.

Descriptor ID	D013274
MeSH Number(s)	C04.588.274.476.767 C06.301.371.767 C06.405.249.767 C06.405.748.789
Concept/Terms	Stomach Neoplasms Stomach Neoplasms Neoplasm, Stomach Stomach Neoplasm Neoplasms, Stomach Gastric Neoplasms Gastric Neoplasm Neoplasm, Gastric Neoplasms, Gastric Cancer of Stomach Cancer of Stomach Stomach Cancers Gastric Cancer Cancer, Gastric Cancers, Gastric Gastric Cancers Stomach Cancer Cancer, Stomach Cancers, Stomach Cancer of the Stomach Gastric Cancer, Familial Diffuse Gastric Cancer, Familial Diffuse

Below are MeSH descriptors whose meaning is more general than "Stomach Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Gastrointestinal Neoplasms [C04.588.274.476]
Stomach Neoplasms [C04.588.274.476.767]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Gastrointestinal Neoplasms [C06.301.371]
Stomach Neoplasms [C06.301.371.767]
Gastrointestinal Diseases [C06.405]
Gastrointestinal Neoplasms [C06.405.249]
Stomach Neoplasms [C06.405.249.767]
Stomach Diseases [C06.405.748]
Stomach Neoplasms [C06.405.748.789]

Below are MeSH descriptors whose meaning is more specific than "Stomach Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Stomach Neoplasms" by people in this website by year, and whether "Stomach Neoplasms" was a major or minor topic of these publications.

Bar chart showing 162 publications over 29 distinct years, with a maximum of 12 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	2	0	2
1996	4	1	5
1997	1	0	1
1998	2	0	2
2000	1	1	2
2001	0	1	1
2002	4	1	5
2003	8	0	8
2004	6	0	6
2005	8	3	11
2006	6	1	7
2007	9	0	9
2008	4	3	7
2009	7	5	12
2010	8	2	10
2011	4	2	6
2012	7	0	7
2013	7	0	7
2014	8	0	8
2015	5	0	5
2016	3	0	3
2017	7	1	8
2018	4	0	4
2019	5	0	5
2020	4	0	4
2021	4	0	4
2022	4	0	4
2023	7	0	7
2024	2	0	2

Below are the most recent publications written about "Stomach Neoplasms" by people in Profiles.

Gallanis AF, Bowden C, Lopez R, Gamble LA, Samaranayake SG, Payne C, Snyder D, Fasaye GA, Joyce S, Broesamle R, Miao N, Miettinen M, Quezado M, Kim SA, Korman L, Heller T, Blakely AM, Hernandez JM, Davis JL. Lessons learned from 150 total gastrectomies for prevention of cancer. J Gastrointest Surg. 2025 Jan; 29(1):101889.

View in: PubMed
Rencuzogullari A, Karahan SN, Selcukbiricik F, Lacin S, Taskin OC, Saka B, Karahacioglu D, Gurses B, Ozoran E, Uymaz DS, Ozata IH, Saglam S, Bugra D, Balik E. The New Era of Total Neoadjuvant FLOT Therapy for Locally Advanced, Resectable Gastric Cancer: A Propensity-Matched Comparison With Standard Perioperative Therapy. J Surg Oncol. 2025 Mar; 131(3):417-426.

View in: PubMed
Green BL, Gamble LA, Diggs LP, Nousome D, Patterson JC, Joughin BA, Gasmi B, Lux SC, Samaranayake SG, Miettinen M, Quezado M, Hernandez JM, Yaffe MB, Davis JL. Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis. Mol Cancer Res. 2023 12 01; 21(12):1356-1365.

View in: PubMed
Peters F, Hohenstein S, Bollmann A, Kuhlen R, Ritz JP. The Postoperative Utilization of Intensive Care Beds After Visceral Surgery Procedures. Dtsch Arztebl Int. 2023 09 22; 120(38):633-638.

View in: PubMed
Stockton S, Catalano P, Cohen SJ, Burtness BA, Mitchell EP, Dotan E, Lubner SJ, Kumar P, Mulcahy MF, Fisher GA, Crandall TL, Benson A. Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial. Oncologist. 2023 09 07; 28(9):827-e822.

View in: PubMed
Zager Y, Goldes Y, Assaf D, Zilka N, Anteby R, Nevo Y, Barda L, Nevler A. Neutrophil to Lymphocyte Ratio in Patients Who Received Neoadjuvant Treatment before Gastrectomy. Isr Med Assoc J. 2023 May; 25(5):336-340.

View in: PubMed
Asif B, Sarvestani AL, Gamble LA, Samaranayake SG, Famiglietti AL, Fasaye GA, Quezado M, Miettinen M, Korman L, Koh C, Heller T, Davis JL. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study. Lancet Oncol. 2023 04; 24(4):383-391.

View in: PubMed
Lin D, Nguyen H, Shah R, Qiao Y, Hartman J, Sugarman R. Quality-adjusted time without symptoms or toxicity analysis of nivolumab plus chemotherapy versus chemotherapy alone for the management of previously untreated patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma. Gastric Cancer. 2023 05; 26(3):415-424.

View in: PubMed
Omarov N, Uymaz DS, Gurbuz B, Selcukbiricik F, Cigtaskin O, Yesilsoy M, Ozoran E, Balik E, Bugra D. Comparison of neoadjuvant versus upfront surgery for treatment of locally advanced gastric cancer. Ann Ital Chir. 2023; 94:569-579.

View in: PubMed
Niroomand E, Kumar SR, Goldberg D, Kumar S. Impact of Medicaid Expansion on Incidence and Mortality from Gastric and Esophageal Cancer. Dig Dis Sci. 2023 04; 68(4):1178-1186.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement